ARTICLE | Company News
ODAC to review Ilex's clofarabine
September 28, 2004 7:00 AM UTC
The FDA's Oncologic Drugs Advisory Committee (ODAC) will review on Dec. 1 ILXO's NDA for clofarabine to treat refractory or relapsed acute leukemia in children. The purine nucleoside analog has a Dec. 30 PDUFA date. ...